-
Camillo Negro and his contributions to Neurology
-
Camptocormia in Parkinson’s disease – impaired kinesthesia of the trunk extensors
-
Can a smartphone accelerometer differentiate between functional and organic tremor ?
-
Can Google Glass improve freezing of gait in parkinsonism? A pilot study
-
Can people with Parkinson’s disease rely on their coping capacity over time? A longitudinal study using the Sense of Coherence (SOC) scale
-
Can Safinamide Help to Stabilize Dopaminergic Treatment in Parkinson’s Disease?
-
Can the Quantified Timed Up and Go (QTUG) device support decision making for patients undergoing Deep Brain Stimulation?
-
Can we hear pathology in premanifest Huntington’s disease? Acoustic and listener-based analysis of speech
-
Cardiac involvement in AVED
-
Cardiovascular autonomic function and MCI in Parkinson’s disease
-
Caregiver burden does not improve in the long-term after deep brain stimulation for Parkinson disease
-
Caregiver support and its association with advanced Parkinson’s disease and clinical outcomes
-
Carotid Intima-Media Thickness and its correlates in people with Parkinson’s disease: a pilot study
-
Carpal Tunnel Syndrome in Patients with Tremor
-
Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism
-
Case of task-specific tremor and task-specific dystonia with contralateral spread
-
Case report: Chorea-acynthocytosis with two compoud heterozygous VPS13A large deletions
-
Case Report: Co-occurrence of Motor Neuron Disease and Parkinsonism
-
Case Series of 3 Individuals of African Descent with Dentatorubral-Pallidoluysian Atrophy
-
Case-control study of risk developing parkinsonism in Alzheimer’s disease in relation to hypertension, dyslipidemia, and diabetes in Taiwan
-
Caudal posterior substantia nigra iron increases longitudinally in Parkinson’s disease
-
Central cholinergic activity and risk of falls in patients with Parkinson’s disease and freezing of gait
-
Central effects of botulinum neurotoxin injections in cervical dystonia – a longitudinal structural MRI-study
-
Central Insulin Resistance Index is Independent of Peripheral Insulin Resistance in Parkinson’s disease
-
Cerebellar ataxia and cutaneous lesions: a clinical case
-
Cerebellar Ataxia in Patients with Huntington’s Disease, an underestimated symptom?
-
Cerebellar brain inhibition and cervical dystonia: exploring clinico-electrophysiological associations
-
Cerebellar involvement in progressive supranuclear palsy and corticobasal degeneration
-
Cerebellar rTMS theta burst for postural instability in progressive supranuclear palsy: a double blind cross-over sham controlled study using wearing sensors technology
-
Cerebellar Structural changes in Patients with Parkinson’s disease and Essential Tremor
-
Cerebellar transcranial magnetic stimulation with neuronavigation for postural instability in PSP
-
Cerebral cavernous malformations and movement disorders
-
Cerebral differences between dopamine-resistant and dopamine-responsive Parkinson’s tremor
-
Cerebral palsy masqueraders in an adult movement disorder tertiary centre: when to investigate an alternative diagnosis?
-
Cerebrotendinous Xanthomatosis presenting Parkinsonism with bilateral iron accumulation in the basal ganglia
-
Certification of cause of death in patients with Parkinson’s Disease (PD)
-
Cervical and Lumbosacral Spondylosis is common in patients with Parkinsonism in rural Western India
-
Challenges in Parkinson’s Disease Diagnosis in a Patient with Ipsilateral Hemimelia
-
Change of extracellular glutamate and GABA level in striatum during deep brain stimulation of the entopeduncular nucleus in rats
-
Changes in close relationships among patients with Parkinson’s disease and their partners following initiation of device-aided treatment
-
Changes in GABAergic transmission of striatal neurons in presymptomatic Huntington’s Disease
-
Changes in Neuromelanin MRI Signal in Parkinson’s Disease: A Longitudinal Study
-
Changes in Supine Blood Pressure with Long Term Use of Droxidopa
-
Changes of cutaneous and cortical silent responses in a random sample of Lithuania patients with Parkinson disease
-
Changes to Speech Production after SpeechVive Treatment in Individuals with Parkinson’s Disease
-
Changing for a rechargeable neurostimulator in Parkinson’s disease patients: safety and feasibility
-
Characterising the role of alpha-synuclein in ferroptotic programmed cell death in the context of Parkinson’s Disease
-
Characteristic Parkinsonism Questionnaire for the Discrimination of Parkinson’s Disease Dementia from Vascular Dementia
-
Characteristics and correlative factors of autonomic dysfunction in Chinese Parkinson’s disease
-
Characteristics and outcome of patients with Parkinson’s disease admitted to intensive care unit
-
Characteristics of African American Parkinson’s Disease patients seen in a Large Clinic Practice
-
Characteristics of arm tremors in primary orthostatic tremor
-
Characteristics of gait and quality of life in Parkinson’s disease
-
Characteristics of lower gastrointestinal tract dysfunction in patients with Parkinson disease
-
Characteristics of patients with essential tremor evaluated for deep brain stimulation surgery at a tertiary center
-
Characteristics of spontaneous brain activity in left- and right-onset Parkinson’s disease patients
-
Characteristics of the clinical and cerebral metabolism in Parkinson’s disease with atrophy in nucleus basalis of Meynert
-
Characterization of cerebrospinal fluid profile in hereditary spastic paraparesis 10
-
Characterization of impulsivity in Colombian patients with Huntington’s disease
-
Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson’s disease
-
Characterization of the motor phenotype and striatal muscle analysis in a mouse model of hereditary spasticity
-
Characterizing olfactory impairment in patients with Parkinson’s disease and related disorders
-
CHCHD2 maintains the MICOS and inhibits PINK1/Parkin mediated mitophagy in an experimental model of Parkinson’s disease
-
Chlorogenic acid and Trianthema portulacastrum combinational therapy mitigates rotenone induced Parkinsonism in wistar rats
-
Chlorogenic acid attenuates the MPTP induced apoptosis in Parkinson’s disease mouse model through pAkt signaling pathway
-
Cholecalciferol (VD3) attenuated motor deficits and dyskinesia in Hemi-Parkinsonian mice: behavioural, biochemical & electrophysiological implications
-
Chorea-acanthocytosis: Challenges in early diagnosis and excellent treatment response to Deep Brain Stimulation (DBS) – a case report
-
Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures
-
Circumstances of Falls in Single and Recurrent Fallers with Parkinson’s Disease
-
Classification of idiopathic cervical dystonia: an observational study
-
Classification of Neurorehabilitation treatments: Preliminary results of a Multicentre Italian Study
-
Classification of spinocerebellar degeneration based on ratio of brainstem white matter to cerebellar gray matter by voxel-based morphometry
-
Classify Parkinson’s Disease with Mild Cognitive Impairment: Machine Learning Approach
-
Clear versus conversational speech in Parkinson’s disease, progressive supranuclear palsy, and multiple system atrophy
-
Clinical and cognitive features of anxiety in Parkinson’s disease
-
Clinical and DAT Imaging Characteristics of Participants with Scans without Evidence of Dopaminergic Deficit (SWEDDs): PPMI Cohort 2 year follow-up
-
Clinical and epidemiological data on Parkinson’s disease in older adults: experience of a single Italian centre.
-
Clinical and fMRI effects of Action Observation and Motor Imagery Training on dual-task performances in Parkinson’s disease patients with postural instability and gait disorders
-
Clinical and genetic characteristics of a new mutation causing Segawa´s disease in a Spanish kindred
-
Clinical and genetic features of paroxysmal kinesigenic dyskinesia (PKD) studied with whole exome sequencing (WES)
-
Clinical and genetic heterogeneity in Indian subcontinent patients with Autosomal Dominant Spinocerebellar Ataxia 42
-
Clinical and imaging characteristics of manifest LRRK2 and GBA carriers: The PPMI cohort
-
Clinical and imaging characteristics of non-manifest LRRK2 and GBA carriers: The PPMI cohort
-
Clinical and molecular features of a Chinese family with spinocerebellar ataxia type 6
-
Clinical and neuroimaging heterogeneity of dementia with Lewy bodies
-
Clinical Applications of Non-Invasive Neuromodulation associated with kinesiotherapy in focal dystonia patients: report of three cases
-
Clinical Associations of Hand Deformities in Parkinson´s Disease
-
Clinical Audit of Hospital Admissions for Parkinson Disease
-
Clinical Characteristics that Impact OnabotulinumtoxinA Treatment Adherence in Patients with Spasticity from ASPIRE
-
Clinical comparison of right onset PD vs left onset PD
-
Clinical Correlates of Genetic and Biomarker Profiles in Patients with Progressive Supranuclear Palsy: Data from the ARISE Study
-
Clinical correlation between 99mTc-TRODAT-1 SPECT and parkinsonism
-
Clinical features of constipation in patients with Parkinson’s disease: a cross-sectional study in China
-
Clinical heterogeneity and neuropathological correlation in progressive supranuclear palsy – description of 4 cases
-
Clinical hypnosis in functional movement disorders: a potential therapeutic strategy
-
Clinical Management of Incipient Wearing-off with the 19-Items Wearing off Questionnaire (WOQ-19)
-
Clinical outcome in early-treated Sepiapterine Reductase Deficiency (SRD): A case report
-
Clinical patterns of gait freezing in Parkinson’s disease and their response to interventions: an observer-blinded study
-
Clinical Profile and Response to EMG-Guided Botulinum toxin (BTX) Injection in Writers’ Cramp (WC)- A Study of 25 Indian Patients
-
Clinical profile and treatment response patterns in patients of Truncal Dystonia: A retrospective case series from a tertiary care hospital in India
-
Clinical profile of idiopathic Parkinson’s disease in patients admitted to Mohamed VI University Hospital center of Marrakech
-
Clinical Response to 72-h Lumbar CSF Drainage in Idiopathic Normal Pressure Hydrocephalus associated with Parkinsonism: Timing and Correlates
-
Clinical Results in Argentines Patients with STN DBS in Parkinson’s Disease
-
Clinical spectrum of Functional Movement Disorders: A clinic based study from a developing country
-
Clinical-instrumental algorithm for assessment visuospatial dysfunction in patients with Parkinson’s disease
-
Clinical, genetic and radiological characterization of patients with movement disorders and basal ganglia calcification
-
Clinical, motor and global cognition in patients with in early stages of Parkinson disease
-
Clinically Relevant Changes in AIMS Based on Clinical and Patient Global Impression of Change in Patients With Tardive Dyskinesia Treated with Deutetrabenazine
-
Clinico-genetic correlation in 102 Spinocerebellar Ataxia Type 12 (SCA 12) patients
-
Clinico-pathological Findings In Autopsy Cases With Non-Specific Glial Tauopathy
-
Clinicopathologic Characterization and Abnormal Autophagy of HDLS
-
Clinimetric properties of direct contemporaneous FOG score rating
-
Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome
-
Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study
-
Co-administration of levodopa and zonisamide reduces the serotonin transporter expression in a rat model of Parkinson’s disease
-
Cockayne Syndrome manifesting as late adult onset cerebellar ataxia: expanding the phenotype
-
Cognition and Gait in Parkinson’s Disease
-
Cognitive ability characterization of rat model with mutated alpha-synuclein overexpression
-
Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full
-
Cognitive changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: A longitudinal study.
-
Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine?
-
Cognitive dysfunction can predict the body weight loss in patients with Parkinson’s disease
-
Cognitive dysfunction in patients with Parkinson’s disease and psychosis
-
Cognitive event related potentials as biomarker of non-motor phenotypes in Parkinson’s Disease
-
Cognitive impairment in Parkinson’s Disease: A cross-sectional association study
-
Cognitive impairment in patients with Parkinson’s Disease
-
Cognitive impairment in patients with Parkinson’s syndrome
-
Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease
-
Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease
-
Cognitive multi-domain assessment in Parkinson’s disease: A more sensitive approach
-
Cognitive outcomes of STN-DBS in GBA mutation carriers with PD
-
Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease
-
Cognitive profile of degenerative parkinsonian syndromes in the French West Indies and relationship with eye movements recordings
-
Cognitive Profile of Patients with Parkinson´s Disease and Subthalamic Nucleus Deep Brain Stimulation
-
Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil
-
Combination Antiretroviral therapy (cART)-induced cerebellar and prefrontal cortex disorders: A Study on the impact of Naringenin and Quercetin
-
Combined Botulinum Toxin and Gpi DBS therapy in intractable cervical dystonia
-
Combined STN and NBM DBS in PD and mild to moderate Parkinson’s dementia
-
Communication Calendar for Interdisciplinary Therapy of Parkinson’s Disease
-
Community Home Care Nurses Training for Parkinson Disease
-
Comorbid Parkinson’s disease and Myasthenia Gravis: A Case-Control Study
-
Comorbid Parkinson’s disease in a Korean patient with Alexander’s disease
-
Comorbidities and medications in Huntington’s disease, Parkinson’s disease and the general population in a US claims database
-
Comparative Grey and White Matter Tau Pathology in LBD and PSP using Digital Histologic Measurements
-
Comparative Study of Dry Needling under Ultrasound Guidance and Extracorporeal Shock Wave Therapy for Myofascial Pain and Spasticity Management
-
Comparing motor and neuropathological features of Parkinson’s disease dementia and dementia with Lewy bodies
-
Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease
-
Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)
-
Comparison of autonomic symptoms on Parkinson’s disease and essential tremor with SCOPA-AUT
-
Comparison of Current DBS Platforms in the United States
-
Comparison of Dementia Patients With and Without Parkinson’s Disease Before Dementia-related Psychosis Occurs: An Administrative Claims Data Analysis
-
Comparison of Gene Expression in Parkinson’s Disease and Bipolar Disorder
-
Comparison of high versus low frequency subthalamic stimulation on eye movement
-
Comparison of LFP-physiomarkers for DBS programming
-
Comparison of motor and non-motor symptoms in operated and medically treated dystonia patients
-
Comparison of motor, non motor symptoms, impulse control disorders and quality of life in patients with young versus late onset Parkinson’s disease
-
Comparison of PDE10A and DAT expression as markers of disease burden in early Parkinson’s disease
-
Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms
-
Compensatory Amygdala Activity during motor timing and selection in PD
-
Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways
-
Complex disease burden in Parkinson’s and Advance Care Planning
-
Complex Training of Balance in Parkinson’s Disease
-
Composite UHDRS shows extensive spatial correlation with grey matter and white matter volume in Huntington’s disease gene carriers
-
Comprehensive clinico-pathophysiological assessment of constipation in Parkinson’s disease
-
Compression Therapy: A Treatment of Rubral Tremor
-
Computerized cognitive test profile of 100 patients with and without Amyloid beta 1-42 burden
-
Computing algorithms can detect bradykinesia from smartphone videos
-
Concentration of short chain fatty acids in the peripheral blood of patients with Parkinson disease
-
Concomitant brain pathologies have no major impact on clinical milestones in progressive supranuclear palsy
-
Connectivity alterations in dopaminergic and cholinergic networks mediate cognitive performance in patients with Parkinson’s disease: a resting-state fMRI study
-
Considerations before initiating therapy in Parkinsonism: basing on the health-related quality of life.
-
Constipation with selected prodromal features increases risk of subsequent Parkinson’s Disease
-
Construct validity of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)
-
Continuous circadian intracerebroventricular administration of anaerobic dopamine: A new therapeutic concept for Parkinson’s disease?
-
Continuous dopaminergic treatment with levodopa/carbidopa intestinal gel in multiple system atrophy: report of three patients
-
Continuous levodopa- carbidopa gel recovers motor cortex plasticity in advanced Parkinson’s disease
-
Contribution of pedunculopontine nucleus cholinergic neurons to L-DOPA-induced dyskinesia and PD motor deficits in hemi-parkinsonian rats
-
Controlling levodopa and deep brain stimulation induced dystonia with interleaving and fractionalized current steering
-
Convalescent Chorea in West Nile Virus Encephalitis
-
Corneal confocal microscopy: An imaging biomarker of neurodegeneration in Parkinson’s disease
-
Correlating subcortical structure and function in idiopathic Parkinson’s disease: A cross-sectional morphometric and [18F]-DOPA PET study
-
Correlation between degree of dysarthria, motor severity and quality of life in patients with Parkinson’s disease
-
Correlation Between Drooling and Quality of Life in Parkinson’s Disease
-
Correlation between Pareidolia and cerebral perfusion by SPECT in Parkinson’s disease without dementia: A retrospective study
-
Correlation Between PDQ-39 and MDS-UPDRS Scores in a Phase 3 Randomized Controlled Trial of Patients with Parkinson’s Disease
-
Correlation between striatal CIT uptake and Mini-Mental State Examination in Parkinson’s disease
-
Correlation between structural neuroimaging and clinical outcomes in a small sample of patients with early Huntington’s disease
-
Correlation between substantia nigra measurement and UPDRS
-
Correlation of local field potentials (LFPs) to electromyography (EMG) of the rostral zona incerta (rZI) and subthalamic nucleus (STN) in Parkinson’s Disease (PD)
-
Correlation of P300 parameters with cognition and impulse control disorders in patients with idiopathic Parkinson’s disease
-
Correlation of Retinal Nerve Fiber Layer Thickness and X-Linked Dystonia Parkinsonism Measured by Spectral-Domain Optical Coherence Tomography
-
Correlations between genetics and cortical dysfunction of paroxysmal kinesgenic dyskinesia
-
Cortical and subcortical atrophy in typical and variant Parkinson-plus syndromes: PROSPECT-M-UK study
-
Cortical cholinergic dysfunction correlates with microglial activation in the Substantia Innominata in patients with REM sleep behavior disorder
-
Cortical excitability in focal dystonia patients using threshold tracking technique
-
Cortical FDG-PET patterns predict long-term motor progression and disability milestones in Parkinson’s disease
-
Cortical gamma oscillations as biomarkers for levodopa-induced dyskinesia
-
Cortical Homeostatic Plasticity Alteration in Cervical Dystonia
-
Cortical thickness analysis in Parkinson’s disease with urinary symptoms
-
Cough sensitivity and aspiration pneumonia in Parkinson’s disease
-
Could we optimize the stimulation parameters setting of directional leads with a patient-specific imaging software in implanted parkinsonian patients?
-
Creutzfeld Jacob disease presenting with functional-appearing, bizarre movements without significant cognitive impairment
-
Creutzfeldt-Jakob disease with a M232R substitution (CJD232) masquerading as parkinson look-alike syndrome
-
CSF levels of NFL (neurofilament light chain) in Parkinsons’ disease patients
-
Cultural bias in performance of motor tasks? Comparison between Japanese and German healthy adults
-
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
2019 International Congress
September 22-26, 2019. Nice, France.